News
Maggioli Group participates to a new European project to clinically validate an artificial intelligence solution for breast cancer treatment planning - the RadioVal project
RadioVal is the first major multi-centre, multi-continental and multi-disciplinary project to clinically validate an artificial intelligence solution for the prediction of patient-specific response to neoadjuvant chemotherapy in breast cancer, in eight clinical centers across Europe, South America, North Africa and Eurasia.
08 February 2023